Hospital Discharge Prescription of Drugs That May Raise Blood Pressure in Patients With Hypertension
Pharmacoepidemiology and Drug Safety · 2025
DOI: 10.1002/pds.70150 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2025. Verfasst von Sarasa Miyake und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Hypertension, Patient Discharge, Blood Pressure, Antihypertensive Agents. Die Arbeit nennt 68 Literaturangaben. Gefördert von: Ministry of Health, Labour and Welfare, Japan, Ministry of Health, Labour and Welfare.
Abstract (Originalsprache)
Purpose
This study aimed to determine the frequency of discharge prescriptions of drugs that may raise blood pressure (BP) in hospitalized patients with hypertension and identify factors associated with these prescriptions.
Methods
A retrospective cross‐sectional analysis was conducted using a nationwide inpatient database in Japan, focusing on adults with hypertension discharged from acute care hospitals between April 2021 and March 2022. The primary outcome was the prescription of drugs that may raise BP at discharge. A multivariable linear probability model was employed to assess the relationship between patient and hospital characteristics and the likelihood of receiving these prescriptions.
Results
Among 979 234 patients with hypertension (mean age: 75.3 years, standard deviation: 13.2), 230 792 (23.6%) received at least one drug that may elevate BP at discharge. Non‐steroidal anti‐inflammatory drugs (NSAIDs) were the most frequently prescribed (46.6%), followed by glucocorticoids (35.3%), atypical antipsychotics (15.1%), antidepressants (7.9%), and Japanese herbal medicines (6.1%). Prescription prevalence was higher among female patients, younger adults, those admitted for medical conditions, non‐emergency hospitalizations, patients with disabilities, and those with a Charlson Comorbidity Index of 1. Patients hospitalized for musculoskeletal or skin conditions, transferred to another hospital, or discharged from high‐volume hospitals were also more likely to receive these prescriptions.
Conclusions
Drugs that may raise BP are commonly prescribed at discharge for patients with hypertension. This highlights the need for targeted interventions to optimize medication management at discharge, aiming to improve BP control and patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.
- Department of Health Services Research, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Public Health Research Group, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
ORCID-Profile: Sarasa Miyake
Förderung
- Ministry of Health, Labour and Welfare, Japan
- Ministry of Health, Labour and Welfare
Zitieren
APA
Miyake, S., Miyawaki, A., Matsui, H., Kimura, Y., & Yasunaga, H. (2025). Hospital Discharge Prescription of Drugs That May Raise Blood Pressure in Patients With Hypertension. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70150
Vancouver
Miyake S, Miyawaki A, Matsui H, Kimura Y, Yasunaga H. Hospital Discharge Prescription of Drugs That May Raise Blood Pressure in Patients With Hypertension. Pharmacoepidemiology and Drug Safety. 2025. doi:10.1002/pds.70150
BibTeX
@article{Miyake2025,
author = {Miyake, Sarasa and Miyawaki, Atsushi and Matsui, Hiroki and Kimura, Yuya and Yasunaga, Hideo},
title = {Hospital Discharge Prescription of Drugs That May Raise Blood Pressure in Patients With Hypertension},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2025},
doi = {10.1002/pds.70150}
}
EUVIMED